SummaryBeta-adrenoceptor blocking drugs are of prophylactic value in some patients with migraine. Beta-adrenoceptor responsiveness as measured by lymphocyte cAMP responsiveness to isoprenaline has, therefore, been compared in ten untreated classical migraine patients and ten matched non-migraine control subjects. Lymphocyte responsiveness to epoprostenol (prostacyclin, PGI2) was also compared. No difference in response to either agent was found between the two groups. A generalized abnormality of betaadrenoceptor function does not appear to be present in classical migraine, but a defect localized to specific vascular regions cannot be excluded.KEY WORDS: isoprenaline, cyclic AMP.
IntroductionThe relationship between cardiovascular, neurological and haematological factors in the pathogenesis of migraine is not understood nor, consequently, is the mode of action of prophylactic migraine treatments. As a preliminary study to examination of beta-adrenoceptor and PGI2 receptor functional status during prophylactic treatment of classical migraine with beta-blockers, we have examined the general responsiveness of these vasodilating receptor systems during attack free periods. Beta-adrenoceptor and PGI2 receptor responsiveness was examined on lymphocytes by measuring isoprenaline and PGI2
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.